Amaranth and its oil inhibit cholesterol biosynthesis in 6-week-old female chickens

Journal of Nutrition

Volumn 126, Issue 8, 1996, Pages 1972-1978

  Qureshi, Asaf A ^a,b   Lehmann, James W ^a,c   Peterson, David M ^a  

^a U S DAIRY FORAGE RESEARCH CENTER   (United States)

^b Advanced Medical Research   (United States)

^c Box 99 ^*  (United States)

Author keywords

amaranth; chickens; cholesterol; cholesterol 7 hydroxylase; tocols

Indexed keywords

ALPHA TOCOTRIENOL; AMARANTH; AMARANTH OIL; BILE ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYPOCHOLESTEROLEMIC AGENT; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SQUALENE; TOCOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY LESION; ARTICLE; CHICKEN; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOOD COMPOSITION; GRAIN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; LIVER MICROSOME; MAIZE; NONHUMAN;

AMARANTHUS; ANGIOSPERMS; ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BODY WEIGHT; CHICKENS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FIBER; FEMALE; FOOD HANDLING; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIVER; PLANT OILS; SEEDS; SOYBEANS; ZEA MAYS;

EID: 0029778898     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Becker, R. (1989) Preparation, composition, and nutritional implications of amaranth seed oil. Cereal Foods World 34: 950-953.
2. Cardozo, M. S. & Eitenmiller, R. R. (1988) Total dietary fiber analysis of selected baked and cereal products. Cereal Foods World 33: 414-419.
3. Chaturvedi, A., Sarojini, G. & Devi, N. L. (1993) Hypocholesterolemic effects of amaranth seed (Amaranthus esculantus). Plant Foods Hum. Nutr. 44: 63-70.
4. Danz, R. A. & Lupton, J. R. (1992) Physiological effects of dietary amaranth (Amaranthus cruentus) on rats. Cereal Foods World 37: 489-494.
5. Garcia, L. A., Alfaro, M. A. & Bressani, R. (1987) Digestibility and protein quality of raw and heat-processed defatted and nondefatted flours prepared with three amaranth species. J. Am. Oil Chem. Soc. 64: 371-375.
6. Goldstein, J. L. &. Brown, M. S. (1990) Regulation of the mevalonate pathway. Nature (Lond.) 343: 425-330.
7. Graham, G. G., Lembeck, J. & Morales, E. (1989) Protein value for children of soft-endosperm maize, alone and with toasted amaranth flour. Nutr. Res. 9: 859-964.
8. Kleinsek, D. A., Jabalquinto, A. M. & Porter, J. W. (1980) In vivo and in vitro mechanisms regulating rat liver β-hydroxy-β-methylglutaryl coenzyme A reductase activity. J. Biol. Chem. 255: 3918-3923.
9. Kottke, B. A., Zinsmeister, A. R., Holmes, D. R., Jr., Kneller, R. W., Hallawar, B. J. & Simon, J.T.M. (1986) Apolipoproteins and coronary heart disease. Mayo Clin. Proc. 61: 313-330.
10. Kritchevsky, D. & Story, J. A. (1978) Fiber, hypercholesteromia and atherosclerosis. Lipids 13: 366-369.
11. Laovoravit, N., Kratzer, F. H. & Becker, R. (1986) The nutritional value of amaranth for feeding chickens. Poult. Sci. 65: 1365-1370.
12. Lehmann, J. W., Putnam, D. H. &. Qureshi, A. A. (1994) Vitamin E isomers in grain amaranths (Amaranthus spp). Lipids 29: 177-181.
13. Leveille, G. A., Romsos, D. R., Yen, Y. Y. & O'Hea, E. K. (1975) Lipid biosynthesis in chicks. A consideration of site of synthesis, influence of diet and possible regulatory mechanisms. Poult. Sci. 54: 1075-1093.
14. Lorenz, K. & Hwang, Y. S. (1985) Lipids in amaranths. Nutr. Rep. Int. 31: 83-89.
15. National Research Council (1989) Diet and Health. Implications for Reducing Chronic Disease. National Academy Press, Washington, DC.
16. Pearce, B. C., Parker, R. A., Deason, M. E., Qureshi, A. A. & Wright, J.J.K. (1992) Hypocholesterolemic activity of synthetic and natural tocotrienols. J. Med. Chem. 35: 3595-3606.
17. Pedersen, B., Bach Knudsen, K. E. & Eggum, B. O. (1990) The nutritive value of amaranth grain (Amaranthus caudatus). 3. Energy and fibre of raw and processed grain. Plant Foods Hum. Nutr. 40: 61-71.
18. Qureshi, A. A., Burger, W. C., Elson, C. E. & Benevenga, N. J. (1982) Effects of cereals and culture filtrate of Trichoderma viride on lipid metabolism of swine. Lipids 17: 924-934.
19. Qureshi, A. A., Burger, W. C., Peterson, D. M. & Elson, C. E. (1986) The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J. Biol. Sci. 261: 10544-10550.
20. Qureshi, A. A., Chaudhary, V., Weber, F. E., Chicoye, E. & Qureshi, N. (1991) Effect of brewer's grain and other cereals on lipid metabolism in chickens. Nutr. Res. 11: 159-168.
21. Qureshi, A. A., Nor, R. M., Gapor, A., Peterson, D. M. & Elson, C. E. (1996) α-Tocopherol attenuates the impact of γ-tocotrienol on 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Nutr. (in press).
22. Qureshi, N. & Qureshi, A. A. (1993) Tocotrienols: novel hypocholesterolemic agents with antioxidant properties. In: Vitamin E in Health and Disease (Packer, L. & Fuchs, J., eds.), pp. 247-267. Marcel Dekker, Inc., New York, NY.
23. Schefer, S., Cheng, F. W., Hauser, S., Batta, A. K. & Salen, G. (1981) Regulation of bile acid synthesis. Measurement of cholesterol 7α-hydroxylase activity in rat liver microsomal preparations in the absence of endogenous cholesterol. J. Lipid Res. 22: 532-536.
24. Singhal, R. S. & Kulkarni, P. R. (1990) Effect of puffing on oil characteristics of amaranth (Rajeera) seeds. J. Am. Oil Chem. Soc. 67: 952-954.
25. Slover, H. T. (1971) Tocopherols in foods and fats. Lipids 6: 291-296.
26. Snedecor, G. W. & Cochran, W. G. (1971) Statistical Methods, 6th ed. Iowa State University Press, Ames, IA.
27. Tillman, P. B. & Waldroup, P. W. (1986) Processing grain amaranth for use in broiler diets. Poult. Sci. 65: 1960-1964.
28. Vohra, P., Bersch, S., Acar, N. & Becker, R. (1989) Use of grain amaranth in diets of Japanese quail and chickens. Nutr. Rep. Int. 39: 1227-1235.
29. Waldroup, P. W., Hellwig, H. M., Longer, D. E. & Endres, C. S. (1985) The utilization of grain amaranth by broiler chickens. Poult. Sci. 64: 759-762.
30. Zannis, V. I. (1989) Molecular biology of human apolipoproteins B and E and associated diseases of lipoprotein metabolism. Adv. Lipid Res. 23: 1-64.